Article
How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Sept 2016
Temming Petra, Arendt Marina, Viehmann Anja, Eisele Lewin, Le Guin Claudia H D, Schündeln Michael M, Biewald Eva, Mäusert Jennifer, Wieland Regina, Bornfeld Norbert, Sauerwein Wolfgang, Eggert Angelika, Lohmann Dietmar R, Jöckel Karl-Heinz
Abstract excerpt
PURPOSE: Intraocular retinoblastoma is curable, but survivors with a heritable predisposition are at high risk for second malignancies. Because second malignancies are associated with high mortality, prognostic factors for second malignancy influence long-term overall survival. This study investigates the impact of all types of eye-preserving therapies on long-term survival in the complete German cohort of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.